Lilly Novo Nordisk - Search News

Novo Nordisk cuts price of weight-loss drug for uninsured

Novo Nordisk to explore how GLP-1 drugs can help patients with addiction

Novo Nordisk will explore how GLP-1 drugs could help patients struggling with addiction, its head of development Martin Holst Lange told an online press conference on Thursday.

USA TODAY on MSN · 3d

Wegovy price cut: Novo Nordisk cuts the price of the weight-loss drug for the uninsured

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight-loss drug Wegovy.

The Washington Post on MSN · 3d

Novo Nordisk slashes Wegovy price for patients lacking insurance benefits

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who can’t get the blockbuster drug through insurance.

Eli Lilly, food and drug administration and Compounders

US judge denies injunction, restricting copies of Lilly weight-loss drug

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and diabetes drugs Zepbound and Mounjaro in the United States.

Federal judge stops compounded copies of Eli Lilly weight loss, diabetes drugs

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs.

News Nation on MSN · 1d

Compounders must stop making copies of Eli Lilly’s weight loss drugs: Judge

Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs.

20mon MSN

Notable healthcare headlines for the week: Walgreens Boots Alliance, AbbVie and Novo Nordisk in focus

Wall Street's major averages dipped for the week as investors wrestled with tariff twists from the Trump administration. The ...

Novo Enters the Ring in Legal Fight Against GLP-1 Compounders as Lilly Notches Victory

Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...

4don MSN

Down 39%. Is Novo Nordisk Stock a Buy on the Dip?

Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...

24/7 Wall St. on MSN12d

HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?

The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO) was ...

3don MSN

Novo Nordisk to sell Wegovy for $499 a month to cash-paying US customers

Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to ...

Medical Marketing & Media1d

Novo, Lilly and Novartis lead pharma’s stellar ad performance at Oscars

While the Super Bowl may not always be the ideal spot for pharma, cultural events like the Oscars can offer a more ...

NovoCare Pharmacy may improve access to Wegovy, but concerns about affordability remain

Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the ...

Novo’s Studies of GLP-1s for Addiction Limited to Ongoing Phase II

Despite comments made by a Novo Nordisk official this week, the company confirmed to BioSpace that it has no additional ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results